Global Regenerative Medicine Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024

Table of Contents

1 Regenerative Medicine Market Overview

• 1.1 Product Overview and Scope of Regenerative Medicine
• 1.2 Classification of Regenerative Medicine by Types
  • 1.2.1 Global Regenerative Medicine Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Regenerative Medicine Revenue Market Share by Types in 2018
  • 1.2.3 Cell Therapy
  • 1.2.4 Tissue Engineering
  • 1.2.5 Biomaterial
  • 1.2.6 Others
• 1.3 Global Regenerative Medicine Market by Application
  • 1.3.1 Global Regenerative Medicine Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Dermatology
  • 1.3.3 Cardiovascular
  • 1.3.4 CNS
  • 1.3.5 Orthopedic
  • 1.3.6 Others
• 1.4 Global Regenerative Medicine Market by Regions
  • 1.4.1 Global Regenerative Medicine Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Regenerative Medicine Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Regenerative Medicine Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Regenerative Medicine Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Regenerative Medicine Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Regenerative Medicine Status and Prospect (2014-2024)
• 1.5 Global Market Size of Regenerative Medicine (2014-2024)

2 Manufacturers Profiles

• 2.1 J & J (DePuy Synthes)
  • 2.1.1 Business Overview
  • 2.1.2 Regenerative Medicine Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Medtronic
  • 2.2.1 Business Overview
  • 2.2.2 Regenerative Medicine Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 ZimmerBiomet
  • 2.3.1 Business Overview
  • 2.3.2 Regenerative Medicine Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 ZimmerBiomet Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Stryker
  • 2.4.1 Business Overview
  • 2.4.2 Regenerative Medicine Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Allergan(Acelity)
  • 2.5.1 Business Overview
  • 2.5.2 Regenerative Medicine Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 MiMedx Group
  • 2.6.1 Business Overview
  • 2.6.2 Regenerative Medicine Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Organogenesis
  • 2.7.1 Business Overview
  • 2.7.2 Regenerative Medicine Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Fujifilm Cellular Dynamics
  • 2.8.1 Business Overview
  • 2.8.2 Regenerative Medicine Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Osiris Therapeutics
  • 2.9.1 Business Overview
  • 2.9.2 Regenerative Medicine Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Vcanbio
  • 2.10.1 Business Overview
  • 2.10.2 Regenerative Medicine Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 CCBC
  • 2.11.1 Business Overview
  • 2.11.2 Regenerative Medicine Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 CCBC Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Cytori
  • 2.12.1 Business Overview
  • 2.12.2 Regenerative Medicine Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Celgene
  • 2.13.1 Business Overview
  • 2.13.2 Regenerative Medicine Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.14 Vericel Corporation
  • 2.14.1 Business Overview
  • 2.14.2 Regenerative Medicine Type and Applications
    • 2.14.2.1 Product A
    • 2.14.2.2 Product B
  • 2.14.3 Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.15 Guanhao Biotech
  • 2.15.1 Business Overview
  • 2.15.2 Regenerative Medicine Type and Applications
    • 2.15.2.1 Product A
    • 2.15.2.2 Product B
  • 2.15.3 Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.16 Mesoblast
  • 2.16.1 Business Overview
  • 2.16.2 Regenerative Medicine Type and Applications
    • 2.16.2.1 Product A
    • 2.16.2.2 Product B
  • 2.16.3 Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.17 AMAG Pharmaceuticals (CBR)
  • 2.17.1 Business Overview
  • 2.17.2 Regenerative Medicine Type and Applications
    • 2.17.2.1 Product A
    • 2.17.2.2 Product B
  • 2.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.18 ViaCord
  • 2.18.1 Business Overview
  • 2.18.2 Regenerative Medicine Type and Applications
    • 2.18.2.1 Product A
    • 2.18.2.2 Product B
  • 2.18.3 ViaCord Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.19 CordLife
  • 2.19.1 Business Overview
  • 2.19.2 Regenerative Medicine Type and Applications
    • 2.19.2.1 Product A
    • 2.19.2.2 Product B
  • 2.19.3 CordLife Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.20 Integra LifeSciences
  • 2.20.1 Business Overview
  • 2.20.2 Regenerative Medicine Type and Applications
    • 2.20.2.1 Product A
    • 2.20.2.2 Product B
  • 2.20.3 Integra LifeSciences Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.21 Nuvasive
  • 2.21.1 Business Overview
  • 2.2.2 Regenerative Medicine Type and Applications
    • 2.21.2.1 Product A
    • 2.21.2.2 Product B
  • 2.21.3 Nuvasive Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.22 Cook Biotech
  • 2.22.1 Business Overview
  • 2.22.2 Regenerative Medicine Type and Applications
    • 2.22.2.1 Product A
    • 2.22.2.2 Product B
  • 2.22.3 Cook Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)
• 2.23 Japan Tissue Engineering
  • 2.23.1 Business Overview
  • 2.23.2 Regenerative Medicine Type and Applications
    • 2.23.2.1 Product A
    • 2.23.2.2 Product B
  • 2.23.3 Japan Tissue Engineering Regenerative Medicine Revenue, Gross Margin and Market Share (2017-2018)

3 Global Regenerative Medicine Market Competition, by Players

• 3.1 Global Regenerative Medicine Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Regenerative Medicine Players Market Share
  • 3.2.2 Top 10 Regenerative Medicine Players Market Share
• 3.3 Market Competition Trend

4 Global Regenerative Medicine Market Size by Regions

• 4.1 Global Regenerative Medicine Revenue and Market Share by Regions
• 4.2 North America Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 4.3 Europe Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 4.5 South America Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Regenerative Medicine Revenue and Growth Rate (2014-2019)

5 North America Regenerative Medicine Revenue by Countries

• 5.1 North America Regenerative Medicine Revenue by Countries (2014-2019)
• 5.2 USA Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 5.3 Canada Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Regenerative Medicine Revenue and Growth Rate (2014-2019)

6 Europe Regenerative Medicine Revenue by Countries

• 6.1 Europe Regenerative Medicine Revenue by Countries (2014-2019)
• 6.2 Germany Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 6.3 UK Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 6.4 France Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 6.5 Russia Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 6.6 Italy Regenerative Medicine Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Regenerative Medicine Revenue by Countries

• 7.1 Asia-Pacific Regenerative Medicine Revenue by Countries (2014-2019)
• 7.2 China Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 7.3 Japan Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 7.4 Korea Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 7.5 India Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Regenerative Medicine Revenue and Growth Rate (2014-2019)

8 South America Regenerative Medicine Revenue by Countries

• 8.1 South America Regenerative Medicine Revenue by Countries (2014-2019)
• 8.2 Brazil Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Regenerative Medicine Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Regenerative Medicine by Countries

• 9.1 Middle East and Africa Regenerative Medicine Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 9.3 UAE Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Regenerative Medicine Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Regenerative Medicine Revenue and Growth Rate (2014-2019)

10 Global Regenerative Medicine Market Segment by Type

• 10.1 Global Regenerative Medicine Revenue and Market Share by Type (2014-2019)
• 10.2 Global Regenerative Medicine Market Forecast by Type (2019-2024)
• 10.3 Cell Therapy Revenue Growth Rate (2014-2024)
• 10.4 Tissue Engineering Revenue Growth Rate (2014-2024)
• 10.5 Biomaterial Revenue Growth Rate (2014-2024)
• 10.6 Others Revenue Growth Rate (2014-2024)

11 Global Regenerative Medicine Market Segment by Application

• 11.1 Global Regenerative Medicine Revenue Market Share by Application (2014-2019)
• 11.2 Regenerative Medicine Market Forecast by Application (2019-2024)
• 11.3 Dermatology Revenue Growth (2014-2019)
• 11.4 Cardiovascular Revenue Growth (2014-2019)
• 11.5 CNS Revenue Growth (2014-2019)
• 11.6 Orthopedic Revenue Growth (2014-2019)
• 11.7 Others Revenue Growth (2014-2019)

12 Global Regenerative Medicine Market Size Forecast (2019-2024)

• 12.1 Global Regenerative Medicine Market Size Forecast (2019-2024)
• 12.2 Global Regenerative Medicine Market Forecast by Regions (2019-2024)
• 12.3 North America Regenerative Medicine Revenue Market Forecast (2019-2024)
• 12.4 Europe Regenerative Medicine Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Regenerative Medicine Revenue Market Forecast (2019-2024)
• 12.6 South America Regenerative Medicine Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Regenerative Medicine Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology